How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Threads in Aesthetic Procedures Market
- By Thread Material: Polydioxanone (PDO) Threads, Poly-L-lactic Acid (PLLA) Threads, Polycaprolactone (PCL) Threads, Silhouette Soft Threads
- By Procedure Type: Facial Lifting, Body Contouring, Scar Revision, Wrinkle Reduction, Double Chin Reduction
- By End-User: Dermatology Clinics, Plastic Surgery Clinics, Medical Spas, Hospitals
- By Thread Configuration: Mono Threads, Cog Threads, Barbed Threads, Screw Threads
- By Application Area: Mid-Face, Lower Face and Jawline, Neck, Forehead and Brow, Cheeks
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polydioxanone (PDO) Threads leads By Thread Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Threads in Aesthetic Procedures Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Thread Material 4
Procedure Type 5
End-User 4
Thread Configuration 4
Application Area 5
Companies profiled
Croma-Pharma GmbH
Mediostar International
Sinclair Pharma (a division of Ipsen)
Luminera Aesthetic
Hugel Inc.
Jeisys Medical Inc.
Dongbang Medical Co. Ltd.
BioScience GmbH
Medytox Inc.
Tianjin Zhengtian Medical Technology Co. Ltd.
HansBiomed Co. Ltd.
MediTox Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Croma-Pharma GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Mediostar International
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sinclair Pharma (a division of Ipsen)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Luminera Aesthetic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Hugel Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Jeisys Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Dongbang Medical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →BioScience GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Medytox Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Tianjin Zhengtian Medical Technology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →HansBiomed Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →MediTox Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →REGENLAB
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →L&P Cosmetic
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Medi-Future
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,428M by 2033 · 6.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polydioxanone (PDO) Threads52.5
- Poly-L-lactic Acid (PLLA) Threads17.2
- Polycaprolactone (PCL) Threads11.2
- Silhouette Soft Threads19.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$288.6M → $433.4M · 5.2%
Europe$201.2M → $313.7M · 5.7%
Asia Pacific$183.7M → $292.2M · 6.0%
Latin America$113.7M → $166.3M · 4.9%
Middle East and Africa$87.5M → $128.4M · 4.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.272026
6.292027
6.292028
6.302029
6.312030
6.332031
6.342032
6.352033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Croma-Pharma GmbH8.4
- Mediostar International20.5
- Sinclair Pharma (a division of Ipsen)10.1
- Luminera Aesthetic10.9
- Hugel Inc.12.8
- Jeisys Medical Inc.9.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Thread Material26.4%
Procedure Type16.5%
End-User21.6%
Thread Configuration16.5%
Application Area19.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.5
- Europe23.5
- Asia Pacific21.9
- Latin America12.5
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Croma-Pharma GmbH | 89 | 80 | 98 | 79 | 98 | 87 | 89 |
| Mediostar International | 77 | 91 | 75 | 73 | 72 | 70 | 76 |
| Sinclair Pharma (a division of Ipsen) | 75 | 70 | 88 | 80 | 78 | 87 | 80 |
| Luminera Aesthetic | 62 | 60 | 73 | 61 | 60 | 69 | 64 |
| Hugel Inc. | 69 | 58 | 76 | 71 | 59 | 68 | 67 |
| Jeisys Medical Inc. | 71 | 69 | 59 | 62 | 51 | 69 | 64 |
| Dongbang Medical Co. Ltd. | 54 | 45 | 55 | 61 | 47 | 57 | 53 |
| BioScience GmbH | 60 | 57 | 51 | 44 | 47 | 38 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Croma-Pharma GmbH
- Mediostar International
- Sinclair Pharma (a division of Ipsen)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Croma-Pharma GmbH | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Mediostar International | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Sinclair Pharma (a division of Ipsen) | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Luminera Aesthetic | ◐ | − | ✓ | − | ◐ | ✓ |
| Hugel Inc. | ◐ | ◐ | ◐ | ✓ | − | ◐ |
| Jeisys Medical Inc. | ◐ | − | ◐ | ◐ | − | ◐ |
| Dongbang Medical Co. Ltd. | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| BioScience GmbH | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Croma-Pharma GmbH89
2Sinclair Pharma (a division of Ipsen)80
3Mediostar International76
4Hugel Inc.67
5Luminera Aesthetic64
6Jeisys Medical Inc.64
7Dongbang Medical Co. Ltd.53
8BioScience GmbH50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Croma-Pharma GmbHSinclair Pharma (a division of Ipsen)
Challenger2
Strong scale, closing on the leaders.
Mediostar InternationalHugel Inc.
Contender2
Focused players with pockets of strength.
Luminera AestheticJeisys Medical Inc.
Niche2
Specialists in a single segment or region.
Dongbang Medical Co. Ltd.BioScience GmbH
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Thread Material in North America, then scale across Threads in Aesthetic Procedures Market — a $265M beachhead inside a $4.58B market.
Beachhead (SOM)$265Mobtainable near-term
Serviceable (SAM)$1.89Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Polydioxanone (PDO) Threads
Best fit — highest urgency & budget in Thread Material.
Economic buyer77 fit
Poly-L-lactic Acid (PLLA) Threads
Strong fit — clear ROI and a fast path to value.
End user67 fit
Polycaprolactone (PCL) Threads
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Thread Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Procedure Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Thread Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Threads in Aesthetic Procedures Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified26%
Evaluation12%
Closed-won6%
$16.9KCAC
$87KLTV
5.2:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Threads in Aesthetic Procedures Market is a resilient opportunity — $2.41B by 2033, compounding at 3.8%.
TAM · 2025$1.79Btoday
TAM · 2033$2.41Bforecast
CAGR3.8%2027–2033
Cumulative$18.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.41BTotal addressable market
SAM$856MServiceable available market
SOM$188MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.8% CAGR
Demand compounds through 2033, outpacing GDP across Thread Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Thread Material moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.41BLarge & growingTAM by 2033 at 3.8% CAGR
$856MServiceable nowreachable with today’s model
$188MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.88BBear2.5% CAGR
$2.41BBase3.8% CAGR
$3.09BBull5.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Procedure Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Threads in Aesthetic Procedures Market — a $4.99B market by 2033. Plan: grow share from 7.4% to 15.2%.
Market size · 2033$4.99Btotal addressable
Market CAGR10.5%2027–2033
Target share15.2%from 7.4% today
Revenue ambition$759Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.4% | 15.2% | At risk |
| Revenue | $401M | $759M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.3% | 45.5% | At risk |
| Customer retention | 85.2% | 96.9% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Thread Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Procedure Type capability
A defensible second engine — invest in Procedure Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Thread Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Procedure Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $83M capacity & capability investment
- Greenlight bolt-on M&A in Procedure Type
- Authorise North America expansion plan
- Fund R&D program for Thread Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Threads in Aesthetic Procedures Market conversation — a $2.04B market you can size, segment and defend in minutes.
Market size · 2033$2.04Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers1,253+accounts in scope
Typical ROI5.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Thread Material
Goal Grow share in Thread Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.6×return on cost, year one
< 3 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Croma-Pharma GmbHMediostar InternationalSinclair Pharma (a division of Ipsen)Luminera AestheticHugel Inc.Jeisys Medical Inc.Dongbang Medical Co. Ltd.BioScience GmbH+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Threads in Aesthetic Procedures Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Threads in Aesthetic Procedures Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Thread Lifting Products Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportThread Lifting Materials Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportTHRAP3 Antibody Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportThorax Lumbus Sacrum Orthosis Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportThoracostomy Tray Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportThoracostomy Procedure Tray Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThoracoscopic Instruments Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportThoraco Lumbo Sacral Support Corset Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThoracolumbosacral Spine Internal Fixation System Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportThoracolumbosacral Orthosis Brace Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportThoracolumbar Vertebral Corpectomy Prosthesis Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportThoracolumbar Stabilization System Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.